FDA Warning Letter — Abbott Laboratories

Case 669353 — FEI 1415939

The FDA took a Warning Letter action against Abbott Laboratories on October 24, 2023 (Abbott Park, IL). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Abbott Laboratories
Date
October 24, 2023
Fiscal Year
2024
Product Type
Biologics
Center
CBER
Location
Abbott Park, IL (United States)